296 related articles for article (PubMed ID: 11964044)
1. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract.
Li CC; Xu B; Hirokawa M; Qian Z; Yoshimoto K; Horiguchi H; Tashiro T; Sano T
Virchows Arch; 2002 Feb; 440(2):145-54. PubMed ID: 11964044
[TBL] [Abstract][Full Text] [Related]
2. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
3. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
[TBL] [Abstract][Full Text] [Related]
4. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
[TBL] [Abstract][Full Text] [Related]
5. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
6. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.
Qian ZR; Li CC; Yamasaki H; Mizusawa N; Yoshimoto K; Yamada S; Tashiro T; Horiguchi H; Wakatsuki S; Hirokawa M; Sano T
Mod Pathol; 2002 Dec; 15(12):1357-65. PubMed ID: 12481018
[TBL] [Abstract][Full Text] [Related]
7. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
[TBL] [Abstract][Full Text] [Related]
8. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis.
Salon C; Moro D; Lantuejoul S; Brichon Py Py; Drabkin H; Brambilla C; Brambilla E
Hum Pathol; 2004 Sep; 35(9):1148-55. PubMed ID: 15343518
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
Zhou YN; Li M
Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
Helpap B; Köllermann J
Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, b-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation.
Li CC; Hirowaka M; Qian ZR; Xu B; Sano T
Endocr Pathol; 2002; 13(1):47-58. PubMed ID: 12114750
[TBL] [Abstract][Full Text] [Related]
17. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
20. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]